Chloroformate Free, Scalable Approach
Letters in Organic Chemistry, 2013, Vol. 10, No. 1 63
(DMSO-d6) 52.45, 113.15, 114.34, 141.01, 148.82, 151.71,
CONFLICT OF INTEREST
154.43.
The author(s) confirm that this article content has no con-
flicts of interest.
Methyl 4-methylpyridin-2-ylcarbamate (2h). White
1
solid, mp 131-132oC, 99% yield, H NMR (CDCl3) ꢁ= 2.36
(s, 3 H), 3.81 (S, 3 H), 4.76 (br, s, 1 H), 6.81-6.82 (d, 2 H, J
= 5.01 Hz), 7.86 (S, 3 H), 8.15-8.17 (d, 2 H, J = 5.1 Hz), 13C
NMR (CDCl3) 21.24, 52.19, 113.01, 119.68, 147.13, 150.01,
152.65, 154.36.
ACKNOWLEDGEMENTS
Mukesh P. Shewalkar is thankful to Dr. A. V. Ramarao
for his guidance and support.
General Procedure for Alkylation (3). To a suspension
of 2 in THF (10 times) and potassium tert-butoxide (1.2Eq),
alkyl halide was added drop wise at 0oC and reaction mixture
was allowed to cool to room temperature. Reaction mixture
was then stirred at the same temperature for 12hr. It was
cooled to 0oC and quenched by water (5 times). Product was
extracted into ethyl acetate. Concentration of organic layer
offered the crude product which was used directly for next
reaction.
REFERENCES
[1]
S. P. Gunasekera, M. Gunasekera, R. E. Longley, G. K. Schulte,
Discodermolide: a new bioactive polyhydroxylated lactone from
the marine sponge Discodermia dissoluta J. Org. Chem., 1990, 55,
4912-4915.
[2]
[3]
M. Bedin, A. M. Gaben, C. Saucier, J. Mester, Geldanamycin, an
inhibitor of the chaperone activity of HSP90, induces MAPK-
independent cell cycle arrest Int. J. Cancer., 2004, 109, 643-652.
T. Bogdanovich, L. M. Ednie, S. Shapiro, P. C. Appelbaum,
Antistaphylococcal Activity of Ceftobiprole,
a New Broad-
Methyl methylpyridin-2-ylcarbamate (3a). Yellow liq-
uid, 99% yield, 1H NMR (CDCl3) ꢁ= 3.45 (s, 3 H), 3.80 (s, 3
H), 7.01-7.05 (m, 1 H), 7.62-7.71 (m, 2 H), 8.38-8.40 (d, 1 H
J = 4.17 Hz); 13C NMR (CDCl3) 34.24, 53.01, 118.97,
119.67, 137.17, 147.58, 154.83, 155.91.
Spectrum Cephalosporin Antimicrob. Agents Chemother. 2005, 49,
4210-4219.
B. G. Katzung, S. Masters, A. Trever, Basic and Clinical Pharma-
cology, McGraw Hill. 2009, 110.
X. M. Yu, G. Shen, L. Neckers, H. Blake, J. Holzbeierlein, B.
Cronk, S. J. Brian, Hsp90 Inhibitors Identified from a Library of
Novobiocin Analogues J. Am. Chem. Soc., 2005, 127, 12778-
12779.
M. Taguchi, K. Goda, K. Sugimoto, T. Akama, K. Yamamoto, T.
Suzuki, Y. Tomishima, M. Nishiguchi, K. Arai, K. Takahashi, T.
Kobori, Biological evaluation of sphingomyelin analogues as in-
hibitors of sphingomyelinase Bioorg. Med. Chem. Lett., 2003, 13,
3681-3684.
[4]
[5]
Methyl ethylpyridin-2-ylcarbamate (3b). Pale yellow
liquid, 99% yield, 1H NMR (CDCl3) ꢁ= 1.19-1.23 (t, 3H, J =
7.02 Hz), 3.78- 4.05 (m, 2 H), 7.02-7.26 (m, 1 H), 7.57-7.68
(m, 2 H), 8.39-8.40 (d, 1 H J = 3.78 Hz); 13C NMR (CDCl3)
14.09, 42.21, 52.83, 119.90, 119.92, 137.21, 147.86, 154.17,
155.61
[6]
[7]
[8]
C. C. McComas, B. M. Crowley, I. Hwang, D. L. Boger, Synthesis
and evaluation of methyl ether derivatives of the vancomycin, tei-
coplanin, and ristocetin aglycon methyl esters Bioorg. Med. Chem.
Lett., 2003, 13, 2933-2936.
K. D. Combrink, D. A. Denton, S. Harran, Z. Ma, K. Chapo, D.
Yan, E. Bonventre, E. D. Roche, T. B. Doyle, G. T. Robertson, A.
S. Lynch, New C25 carbamate rifamycin derivatives are resistant to
inactivation by ADP-ribosyl transferases Bioorg. Med. Chem. Lett.,
2007, 17, 522-526.
A. Decor, B. Monse, M. T. Martin, A. Chiaroni, S. Thoret, D. Gue-
nard, F. Gueritte, O. Baudoin, Synthesis and biological evaluation
of B-ring analogues of (ꢀ)-rhazinilam Bioorg. Med. Chem. 2006,
14, 2314-2332.
D. Christophe, D. Guenard, C. Thal, S. Thoret, F. Gueritte, Synthe-
sis of a rhazinilam analogue acting as an inhibitor of tubulin as-
sembly Tet. Lett., 2000, 41, 5853-5856.
C. Borrel, S. Thoret, X. Cachet, D. Guenard, F. Tillequin, M. Koch,
S. Michel, New antitubulin derivatives in the combretastatin A4 se-
ries: synthesis and biological evaluation Bioorg. Med. Chem., 2005,
13, 3853-3856.
S. Kupchinsky, S. Centioni, T. Howard, J. Trzupek, S. Roller, V.
Carnahan, H. Townes, B. Purnell, C. Price, H. Handl, K. Sum-
merville, K. Johnson, J. Toth, S. Hudson, K. Kiakos, J. A. Hartley,
M. Lee, A novel class of achiral seco-analogs of CC-1065 and the
duocarmycins: design, synthesis, DNA binding, and anticancer
properties Bioorg. Med. Chem., 2004, 12, 6221-6225.
R. D. Gonzales, P. C. Schreckenberger, M. B. Graham, S. Kelkar,
K. DenBesten, J. P. Quinn, Infections due to vancomycin-resistant
Enterococcus faecium resistant to linezolid The Lancet, 2001, 357,
1179-1183.
Methyl benzylpyridin-2-ylcarbamate (3c). Pale brown
liquid, 99.5% yield, 1H NMR (CDCl3) ꢁ= 3.76 (s, 3 H), 5.24
(s, 2 H), 7.01-7.05 (m, 1 H), 7.20-7.21 (m, 5 H), 7.62-7.63
(m, 2 H), 8.38-8.40 (d, 1 H, J = 4.53 Hz); 13C NMR (CDCl3)
50.01, 53.06, 119.80, 120.06, 126.95, 127.45, 128.29,
137.32, 138.62, 147.82, 153.95, 155.82.
General Procedure for Hydrolysis (4). 10% of aq.
NaOH (8times), methanol (2times) and (3) were refluxed for
3hr. After cooling to room temperature the product was ex-
tracted into ethyl acetate. Concentration of organic layer
yielded the crude product which was purified by either
distillation or recrystallization.
[9]
[10]
[11]
N-methylpyridin-2-amine (4a). Color less liquid, 97%
1
yield, H NMR (CDCl3) ꢁ= 2.90-2.92 (d, 3 H, J = 5.1 Hz),
4.57 (br, s, 1 H), 6.36-6.39 (d, 1 H, J = 8.37 Hz), 6.54-6.58
(m, 1 H), 7.39-7.44 (m, 1H), 8.08-8.09 (d, 1 H, J = 3.96 Hz),
13C NMR (CDCl3) 28.89, 106.20, 112.40, 137.29, 147.98,
159.73.
[12]
N-ethylpyridin-2-amine (4b). Color less liquid, 96%
1
yield, H NMR (CDCl3) ꢁ= 1.23-1.27 (t, 3H, J = 7.17 Hz),
[13]
[14]
3.25- 3.34 (m, 2 H), 4.45 (br, s, 1H), 6.35-6.37 (m, 1 H),
7.38-7.43 (m, 1 H), 8.06-8.08 (d, 1 H, J = 3.87 Hz), 13C
NMR (CDCl3) 14.81, 36.82, 106.33, 112.54, 137.32, 112.54,
137.32, 148.12, 158.92
R. Berisio, J. Harms, F. Schluenzen, R. Zarivach, A. S. Hansen, P.
Fucini, A. Yonath, Structural Insight into the Antibiotic Action of
Telithromycin against Resistant Mutants J. Bacteriol. 2003, 185,
4276-4279.
N-benzylpyridin-2-amine (4c). White solid, mp 88-90oC
1
(methanol), 98% yield, H NMR (CDCl3) ꢁ= 4.49-4.51 (d, 2
[15]
[16]
D. Chaturvedi, Perspectives on the synthesis of organic carbamates
Tetrahedron, 2012, 68, 15-45 and the references cited therein.
M. Kawasaki, Y. Suzuki, S. Terashima, Asymmetric reduction of
prochiral cyclic ketones with lithium aluminum hydride partially
H, J = 5.52 Hz), 4.88 (br, s, 1 H), 6.35-6.38 (d, 1 H, J = 8.31
Hz), 6.56-6.60 (m, 1 H), 7.28-7.41 (m, 6 H), 8.09-8.11 (d, 1
H, J = 3.75 Hz); 13C NMR (CDCl3) 46.34, 106.79, 113.14,
127.23, 127.41, 128.68, 137.48, 139.23, 148.21, 158.70.